Biotech IPOs, Biosecure Act, cachexia pipeline — a BioCentury podcast

Biotech’s largest-ever IPO, leaders in the clinic for cachexia, and the latest from Washington

Biotech IPOs that are getting out remain hot — but will that continue into the fall? On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the market for fresh biotech paper on NASDAQ, including the $770 million debut by  Parabilis Medicines Inc. (NASDAQ:PBLS), the largest IPO in the sector’s history.

The analysts also discuss the Biosecure Act and U.S. policy toward China; the cachexia pipeline; and BioCentury’s updated Innovation Distillery.